Product Image
Invitrogen™

Champion™ pET100 Directional TOPO™ Expression Kit with BL21 Star™ (DE3) One Shot™ Chemically Competent E. coli

Das Champion™ pET Expressionssystem liefert die höchste Proteinproduktion in E. coli. Während der Expression kann Ihr gewünschtes Protein einen AnteilWeitere Informationen
Have Questions?
KatalognummerMenge
K1000120 Reaktionen
Katalognummer K10001
Preis (EUR)
1.274,00
Each
Menge:
20 Reaktionen
Preis (EUR)
1.274,00
Each
Das Champion™ pET Expressionssystem liefert die höchste Proteinproduktion in E. coli. Während der Expression kann Ihr gewünschtes Protein einen Anteil von mehr als 50 % des gesamten zellulären Proteins erreichen. Basierend auf T7-Expressionsvektoren, die ursprünglich von Studier und Kollegen (1-3) entwickelt wurden, wird eine starke Expression erreicht, da die T7-RNA-Polymerase prozessiver ist als die native E. coli-RNA-Polymerase und sie der Transkription Ihre Genen von Interesse gewidmet ist. Die Proteinproduktion wird im System durch den Expressionsstamm BL21 Star™ E. coli weiter verbessert, der die Stabilität von mRNA-Transkripten signifikant verbessert und die Proteinexpression auf das bis zu Zehnfache erhöht

Das vereinfachte und effiziente direktionale TOPO™ Klonen ermöglicht die schnelle Eingabe eines Champion™ pET-Expressionsvektors. Diese Kits verfügen über linearisierte mit Topoisomerase I aktivierte Champion™ pET-Expressionsvektoren für eine direktionale Klonierung innerhalb von fünf Minuten. Die Technologie der direktionalen TOPO™ Klonierung erleichtert die Genexpression aus folgenden Gründen:

• Ein Korrekturleseenzym wird für die PCR verwendet, was zu weniger Fehlern bei geklonten Genen führt
• Mehr als 90 % der Klone befinden sich in der richtigen Ausrichtung für die Genexpression, wodurch die Zeit für das Kolonie-Screening reduziert wird

Sieben Champion™ pET-direktionale TOPO™ Expressionsvektoren sind lieferbar (Abbildung 1 und Tabelle 1): Jeder Vektor trägt einen T7lac-Promotor für die High-Level-Expression. Es stehen flexible Optionen zur Vereinfachung der Proteindetektion, zur Spaltung von Aufreinigungsmarkern, zur Auswahl von Plasmid-Trägerklons und/oder zur Verbesserung der Proteinausbeute zur Verfügung.
Mit den Champion™ pETdirektionalen TOPO™ Vektoren können Sie höchste Proteinproduktionen erwarten. Abbildung 2 zeigt die Expression des lacZ-Gens in Champion™ pET-direktionalen TOPO™ Vektoren. Abbildung 3 zeigt eine effiziente Spaltung mittels TEV-Protease des N-terminalen Tags eines aus pET151/D-TOPO™ exprimierten β-Galactosidase-Fusionsproteins.
Nur für Forschungszwecke. Nicht zur Verwendung bei diagnostischen Verfahren.
Specifications
Bakterielle AntibiotikaresistenzAmpicillin (AMPR)
Bakterien- oder HefenstammBL21 Star™(DE3)
SpaltungEK (Enterokinase)-Erkennungsstelle
Konstitutives oder induktives SystemInduzierbar
ExpressionsmechanismusZellbasierte Expression
ExpressionssystemE. coli
InduktionsmittelIPTG
ProdukttypTOPO Expressionskit
Menge20 Reaktionen
Selektionsmittel (eukaryotisch)Keine
VektorpET
KlonierungsmethodeDirektionales TOPO™
ProduktlinieOne Shot
PromoterT7, lacO
ProteinmarkierungHis-Tag (6x), Xpress Epitop-Tag
Unit SizeEach
Inhalt und Lagerung
Jedes Champion™ pET-direktionale TOPO™ Expressionskit wird als komplettes Expressionssystem geliefert. Die Box für die direktionale TOPO™ Expression enthält 200 ng linearisierten, mit Topoisomerase I aktivierten Champion™ pET-Vektor, steriles Wasser, dNTPs, 10x PCR-Puffer, Kochsalzlösung, Kontroll-Template und -Primer, Primer für Sequenzierung oder PCR-Screening und eine Expressionskontrolle. Bei -20°C lagern. Die One Shot™ TOP10 Box enthält einundzwanzig 50 µl-Aliquoten chemisch kompetenter E. coli, S.O.C.-Medium und ein Kontrollplasmid. Bei -80°C lagern. Die One Shot™ BL21 Star™(DE3)-Box enthält einundzwanzig 50 µl-Aliquoten chemisch kompetenter E. coli, S.O.C.-Medium und ein Kontrollplasmid. Bei -80°C lagern. Kits mit Lumio™ Technologie enthalten 20 µl Lumio™ Detektionsreagenz. Bei -20°C lagern. Bei ordnungsgemäßer Lagerung garantiert 6 Monate stabil.

Häufig gestellte Fragen (FAQ)

My gene of interest is toxic to bacterial cells. Are there any precautions you can suggest?

Several precautions may be taken to prevent problems resulting from basal level expression of a toxic gene of interest. These methods all assume that the T7-based or Champion-based expression plasmid has been correctly designed and created.

- Propagate and maintain your expression plasmid in a strain that does not contain T7 RNA polymerase (i.e., DH5α).
- If using BL21 (DE3) cells, try growing cells at room temperature rather than 37 degrees C for 24-48 hr.
- Perform a fresh transformation using a tightly regulated E. coli strain, such as BL21-AI cells.
- After following the transformation protocol, plate the transformation reaction on LB plates containing 100 µg/mL ampicillin and 0.1% glucose. The presence of glucose represses basal expression of T7 RNA polymerase.
- Following transformation of BL21-AI cells, pick 3 or 4 transformants and inoculate directly into fresh LB medium containing 100 µg/mL ampicillin or 50 µg/mL carbenicillin (and 0.1% glucose, if desired). When the culture reaches an OD600 of 0.4, induce expression of the recombinant protein by adding L-arabinose to a final concentration of 0.2%.
- When performing expression experiments, supplement the growth medium with 0.1% glucose in addition to 0.2% arabinose.
- Try a regulated bacterial expression system such as our pBAD system.

Find additional tips, troubleshooting help, and resources within our Protein Expression Support Center.

I'm trying to express my protein using a bacterial expression system. How do I know if I'm seeing degradation of my protein or if what I’m seeing is codon usage bias?

Typically, if you see 1-2 dominant bands, translation stopped prematurely due to codon usage bias. With degradation, you usually see a ladder of bands. With degradation, you can try using a protease inhibitor and add it to the lysis buffer to help prevent degradation. If degradation is the issue, a time point experiment can be done to determine the best time to harvest the cells.

Find additional tips, troubleshooting help, and resources within our Protein Expression Support Center.

I'm trying to express my protein using a bacterial expression system and am getting inclusion bodies. What should I do?

If you are having a solubility issue, try to decrease the temperature or decrease the amount of IPTG used for induction. You can also try a different, more stringent cell strain for expression. Adding 1% glucose to the bacterial culture medium during expression can also help.

Find additional tips, troubleshooting help, and resources within our Protein Expression Support Center.

I'm getting low protein yield from my bacterial expression system. What can I do to improve this?

- Inoculate from fresh bacterial cultures, since higher protein yields are generally obtained from a fresh bacterial colony.

- Check the codon usage in the recombinant protein sequence for infrequently used codons. Replacing the rare codons with more commonly used codons can significantly increase expression levels. For example, the arginine codons AGG and AGA are used infrequently by E. coli, so the level of tRNAs for these codons is low.

- Add protease inhibitors, such as PMSF, to buffers during protein purification. Use freshly made PMSF, since PMSF loses effectiveness within 30 min of dilution into an aqueous solution.

- If you are using ampicillin for selection in your expression experiments, you may be experiencing plasmid instability due to the absence of selective conditions. This occurs as the ampicillin is destroyed by β-lactamase or hydrolyzed under the acidic media conditions generated by bacterial metabolism. You may want to substitute carbenicillin for ampicillin in your transformation and expression experiments.

- The recombinant protein may be toxic to bacterial cells. Try a tighter regulation system for competent cell expression such as BL21-AI. You may also consider trying a different expression system such as the pBAD system.

Find additional tips, troubleshooting help, and resources within our Protein Expression Support Center.

My cells are growing very slowly, and I'm not getting any protein expression from my baterial expression system. What can I do to fix this?

This typically occurs when your gene of interest is toxic. Try using a tighter regulation system, such as BL21 (DE3) (pLysS) or BL21 (DE3) (pLysE), or BL21(AI).

Find additional tips, troubleshooting help, and resources within our Protein Expression Support Center.

Zitierungen und Referenzen (14)

Zitierungen und Referenzen
Abstract
The protein phosphatases of Synechocystis sp. strain PCC 6803: open reading frames sll1033 and sll1387 encode enzymes that exhibit both protein-serine and protein-tyrosine phosphatase activity in vitro.
Authors:Li R,Potters MB,Shi L,Kennelly PJ
Journal:Journal of bacteriology
PubMed ID:16109928
The open reading frames (ORFs) encoding two potential protein-serine/threonine phosphatases from the cyanobacterium Synechocystis sp. strain PCC 6803 were cloned and their protein products expressed in Escherichia coli cells. The product of ORF sll1033, SynPPM3, is a homologue of the PPM family of protein-serine/threonine phosphatases found in all eukaryotes as ... More
A TFIIB-like protein is indispensable for spliced leader RNA gene transcription in Trypanosoma brucei.
Authors:Schimanski B, Brandenburg J, Nguyen TN, Caimano MJ, Günzl A,
Journal:Nucleic Acids Res
PubMed ID:16554554
'The lack of general class II transcription factors was a hallmark of the genomic sequences of the human parasites Trypanosoma brucei, Trypanosoma cruzi and Leishmania major. However, the recent identification of TFIIA as part of a protein complex essential for RNA polymerase II-mediated transcription of SLRNA genes, which encode the ... More
A GPI-linked carbonic anhydrase expressed in the larval mosquito midgut.
Authors:Seron TJ, Hill J, Linser PJ,
Journal:J Exp Biol
PubMed ID:15579552
'We have previously described the first cloning and partial characterization of carbonic anhydrase from larval Aedes aegypti mosquitoes. Larval mosquitoes utilize an alkaline digestive environment in the lumen of their anterior midgut, and we have also demonstrated a critical link between alkalization of the gut and carbonic anhydrase(s). In this ... More
Biophysical characterization of the interaction domains and mapping of the contact residues in the XPF-ERCC1 complex.
Authors:Choi YJ, Ryu KS, Ko YM, Chae YK, Pelton JG, Wemmer DE, Choi BS,
Journal:J Biol Chem
PubMed ID:15932882
'XPF and ERCC1 exist as a heterodimer to be stable and active in cells andatalyze DNA cleavage on the 5''-side of a lesion during nucleotide excision repair. To characterize the specific interaction between XPF and ERCC1, we expressed the human ERCC1 binding domain of XPF (XPF-EB) and the XPF binding ... More
ADAMTS13 substrate recognition of von Willebrand factor A2 domain.
Authors:Zanardelli S, Crawley JT, Chion CK, Lam JK, Preston RJ, Lane DA,
Journal:J Biol Chem
PubMed ID:16221672
'ADAMTS13 controls the multimeric size of circulating von Willebrand factor (VWF) by cleaving the Tyr1605-Met1606 bond in theA2 domain. To examine substrate recognition, we expressed in bacteria and purified three A2 (VWF76-(1593-1668), VWF115-(1554-1668), VWFA2-(1473-1668)) and one A2-A3 (VWF115-A3-(1554-1874)) domain fragments. Using high pressure liquid chromatography analysis, the initial rates of ... More